OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psilocybin for Trauma-Related Disorders
Amanda Khan, Ellen Bradley, Aoife O’Donovan, et al.
Current topics in behavioral neurosciences (2022), pp. 319-332
Closed Access | Times Cited: 25

Showing 25 citing articles:

The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
Emma I Kopra, Jason Ferris, Adam Winstock, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 733-748
Open Access | Times Cited: 34

Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity
Yingjie Du, Yunfeng Li, Xiangting Zhao, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 31

Psilocybin Facilitates Fear Extinction: Importance of Dose, Context, and Serotonin Receptors
Samuel C. Woodburn, Caleb M. Levitt, A. Koester, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 16, pp. 3034-3043
Open Access | Times Cited: 7

Update on treatments for anxiety-related disorders
Hyun Jeong Lee, Murray B. Stein
Current Opinion in Psychiatry (2022) Vol. 36, Iss. 2, pp. 140-145
Closed Access | Times Cited: 19

Psilocybin-assisted therapy and HIV-related shame
Nicky J. Mehtani, Mallory O. Johnson, Peter S. Hendricks, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
Daniel A Kinderlehrer
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 141-155
Open Access

The effect of low-dose psilocybin on brain neurotransmission and rat behavior
Agnieszka Bysiek, Adam Wojtas, Izabela Szpręgiel, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111347-111347
Closed Access

Disruptive Psychopharmacology
Frederick S. Barrett, Katrin H. Preller
Current topics in behavioral neurosciences (2022)
Closed Access | Times Cited: 17

Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review
Lakshan N Fonseka, Benjamin K.P. Woo
World Journal of Psychiatry (2023) Vol. 13, Iss. 5, pp. 182-190
Open Access | Times Cited: 7

Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors
Samuel C. Woodburn, Caleb M. Levitt, A. Koester, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study
Daniel A Kinderlehrer
International Medical Case Reports Journal (2023) Vol. Volume 16, pp. 109-115
Open Access | Times Cited: 6

The position statement of the Working Group on the treatment of post-traumatic stress disorders in adults
Tytus Koweszko, Bogdan de Barbaro, Bernadetta Izydorczyk, et al.
Psychiatria Polska (2023) Vol. 57, Iss. 4, pp. 705-727
Open Access | Times Cited: 4

Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder
Claire Miller, Phillip R. Zoladz
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 1, pp. 100026-100026
Closed Access | Times Cited: 1

Expert recommendations for Germany’s integration of psychedelic-assisted therapy
Sergio R Pérez Rosal, Joseph La Torre, Susanne Birnkammer, et al.
BMC Medical Education (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

A narrative exploration of psilocybin’s potential in mental health
Han-Tsung Min, Soon-Young Park, Jisu Park, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access

References

Immune system (2024), pp. 471-578
Closed Access

Posttraumatic Stress Disorder
Hymie Anisman, Shawn Hayley, Alexander W. Kusnecov
Immune system (2024), pp. 293-322
Closed Access

Trauma and Remembering: From Neuronal Circuits to Molecules
Szabolcs Kéri
Life (2022) Vol. 12, Iss. 11, pp. 1707-1707
Open Access | Times Cited: 2

Neurociência do canabidiol – aspectos neurocognitivos, terapêuticos e comportamentais
Fernando Campos Barbosa, Rodrigo Martins Tadine, Janaína Drawanz Pereira Rezende, et al.
OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA (2023) Vol. 21, Iss. 8, pp. 8891-8914
Open Access

Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge
Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś
Journal of Education Health and Sport (2023) Vol. 50, Iss. 1, pp. 62-75
Open Access

Page 1

Scroll to top